
Keywords: Combination chemotherapy; Lung cancer; Mathematical modeling and computational simulation; Gemcitabine and cisplatin; Pharmacokinetics and pharmacodynamics; 2D; Two-dimensional; AUC; Area-under-the-curve; CDDP; Cisplatin (cis-diamminedichloroplatinum(II))